Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)
| 7.06 Delayed Data As of Jul 01 |  +0.05 / +0.71%Today’s Change | 4.81 Today|||52-Week Range 8.65 | +4.28% Year-to-Date |
Latest CPRX News | Press Releases
| 5 "Strong Buy" Pharmaceutical Stocks to Own for the Long Haul Jun 29 / StockNews.com - Paid Partner Content |
Today’s Trading
| Previous close | 7.01 |
| Today’s open | 6.99 |
| Day’s range | 6.87 - 7.10 |
| Volume | 1,248,458 |
| Average volume (3 months) | 1,157,551 |
| Market cap | $724.6M |
Data as of 3:59pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | -47.28% |
| Earnings growth (this year) | +82.16% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +18.27% |
| P/E ratio | 16.8 |
| Price/Sales | 5.18 |
| Price/Book | 3.51 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TBPHTheravance Biopharma... | +0.67 | +7.40% |
| KNSAKiniksa Pharmaceutic... | +0.43 | +4.44% |
| YMABY-mAbs Therapeutics ... | +0.21 | +1.39% |
| CTICCTI Biopharma Corp | +0.11 | +1.84% |
Data as of 5:57pm ET, 07/01/2022
Financials
| Next reporting date | August 10, 2022 |
| EPS forecast (this quarter) | $0.17 |
| Annual revenue (last year) | $140.8M |
| Annual profit (last year) | $39.5M |
| Net profit margin | 28.03% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Coral Gables, Florida |
Forecasts
